<p>The mice bearing large tumor (<i>n</i> = 9 for each group, A) and those bearing small tumor (<i>n</i> = 6 for each group, B) were injected intravenously with NanoX (•), InNanoX (▽), NanoVNB (▪) or InVNBL (◊) at 0, 7, and 14 days after first injection (arrow; three injections total). The zero time point indicates the initiation of therapy. Data were expressed as mean ± S.E.M.</p
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>Three formulations (Dox alone, CL-Dox and Gal-Dox) were introduced into tumor-bearing mice on day...
[[abstract]]Background: Nanoliposomes are designed as carriers capable of packaging drugs through pa...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, tumor volume 102.4±22.0 mm<sup>3</sup>...
*<p>: <i>p</i><0.05,</p>**<p>: <i>p</i><0.01 compared with control group (NanoX).</p
<p>Mice were treated with liposomal drugs (NanoVNB, InNanoX, InVNBL and NanoX as a control) at Day 0...
[[abstract]]Objectives PEGylated liposomes are important drug carriers, which can passively target t...
PURPOSE: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
[[abstract]]Purpose: PEGylated liposomes are important drug carriers that can passively target tumor...
Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
<p>(A) Suppression of tumor growth measured by volume in each treatment group. Points, mean; bars, S...
<p>The large-tumor mice receiving various liposomal drugs were intraperitoneally injected with 150 m...
<p>The scintigraphic imaging was performed for 20 min at 48 h after drugs administration (37 MBq/100...
a<p>Gamma photon counts per pixel (Counts/pixel) and tumor-to-muscle ratio (T/M) were determined fro...
[[abstract]]PEGylated liposomes are important drug carriers for nanomedicine cancer therapy. PEGylat...
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>Three formulations (Dox alone, CL-Dox and Gal-Dox) were introduced into tumor-bearing mice on day...
[[abstract]]Background: Nanoliposomes are designed as carriers capable of packaging drugs through pa...
<p>The mice bearing large tumor (<i>n</i> = 9 for each group, tumor volume 102.4±22.0 mm<sup>3</sup>...
*<p>: <i>p</i><0.05,</p>**<p>: <i>p</i><0.01 compared with control group (NanoX).</p
<p>Mice were treated with liposomal drugs (NanoVNB, InNanoX, InVNBL and NanoX as a control) at Day 0...
[[abstract]]Objectives PEGylated liposomes are important drug carriers, which can passively target t...
PURPOSE: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
[[abstract]]Purpose: PEGylated liposomes are important drug carriers that can passively target tumor...
Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced...
<p>(A) Suppression of tumor growth measured by volume in each treatment group. Points, mean; bars, S...
<p>The large-tumor mice receiving various liposomal drugs were intraperitoneally injected with 150 m...
<p>The scintigraphic imaging was performed for 20 min at 48 h after drugs administration (37 MBq/100...
a<p>Gamma photon counts per pixel (Counts/pixel) and tumor-to-muscle ratio (T/M) were determined fro...
[[abstract]]PEGylated liposomes are important drug carriers for nanomedicine cancer therapy. PEGylat...
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>Three formulations (Dox alone, CL-Dox and Gal-Dox) were introduced into tumor-bearing mice on day...
[[abstract]]Background: Nanoliposomes are designed as carriers capable of packaging drugs through pa...